CMS to Address Problems with Hospice Reporting of Anti-Cancer and Anti-Emetic Drugs on Claims

Since imposition of the requirement to report prescription drugs on hospice claims in April 2014, some hospices have had claims reporting anti-cancer and anti-emetic drugs returned to provider (RTP). The Centers for Medicare & Medicaid Services (CMS) and the Medicare Administrative Contractors (MACs) have discovered that this is occurring because the Common Working File (CWF)…